- APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region Mar 22 SINGAPORE (March 22, 2023)– Asia Pacific Medical Technology Association (APACMed), the region’s leading organization for medical... read more
- Final Definitions and Considerations for Trading Partners to Prepare for DSCSA Implementation Mar 21 From Quarles, Newsletter, 3.21. 2023 On March 16, 2023, the Food and Drug Administration (FDA) released... read more
- Frier Levitt Announces Webinar Series on Navigating State Boards of Pharmacy Mar 20 Join NASP member Frier Levitt for a complimentary webinar series beginning March 29, 2023, “Navigating State... read more
- Spotlight: Corporate Member of the Month, March 2023 Mar 20 NASP is pleased to shine a bright light this week on Ochsner Specialty Pharmacy, the third... read more
- H.R. 1613 – Drug Price Transparency in Medicaid Act Mar 17 Congress Takes Action to Address Anticompetitive PBM Practices in the Medicaid Program WASHINGTON, DC – On... read more
- Spotlight: Corporate Member of the Month, March 2023 Mar 13 NASP is pleased to shine a bright light this week on St. Elizabeth Healthcare Specialty Pharmacy,... read more
- Spotlight: Corporate Member of the Month, March 2023 Mar 06 NASP is pleased to shine a bright light this week on BioTek reMEDys, the first corporate... read more
- Spotlight: Corporate Members of the Month, March 2023 Mar 01 NASP is pleased to announce the March Spotlight: NASP Corporate Members of the Month! This month, we’ll... read more
- Eversana Consulting Named a Top Ranked Consulting Firm by Vault Across Asia Pacific Feb 23 SINGAPORE & CHICAGO – February 22, 2023 – EVERSANA®, a pioneer of next-generation commercial services to... read more
- Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL) Feb 23 STOCKHOLM – February 23, 2023 – Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement... read more